Intel

Intel filed an 8-K combining a Regulation FD disclosure (Item 7.01) and an Other Material Events item (8.01), suggesting the company issued forward-looking guidance or management commentary alongside a separately material non-routine development — a pairing that often accompanies investor presentations, strategic updates, or significant operational announcements. The 8.01 item is a catch-all that can cover anything from restructuring actions to major partnerships; absent more context it elevates the filing above routine. Full filing body not analyzed; description inferred from form + item codes. PMs should pull the actual exhibit to assess whether the Reg FD content revises near-term outlook and what the 8.01 event entails.

Intel's 10-Q for the quarter ended June 27, 2026 covers revenue, gross margins, segment results (Client Computing Group, Data Center & AI, Intel Foundry), and any updated full-year outlook. Full filing body not analyzed; description inferred from form + item codes. PMs should watch for Intel Foundry ramp progress, AI/server demand trends, and any revision to cost-reduction targets under the ongoing restructuring.

Intel filed an 8-K disclosing quarterly results of operations (Item 2.02), almost certainly accompanied by a press release covering revenue, gross margin, and forward guidance. Full filing body not analyzed; description inferred from form + item codes. PMs should watch for data-center / AI accelerator segment performance and any revision to the full-year outlook, both of which directly affect the KR/TW memory and logic supply chain.

Routine 8-K reporting outcomes of the annual meeting shareholder votes (director elections, auditor ratification, say-on-pay, and any proposals). Typically non-market-moving unless a director failed to receive majority support or a shareholder proposal passed against the board's recommendation. Full filing body not analyzed; description inferred from form + item codes.

Intel filed an 8-K under Item 8.01 (Other Material Events) with Item 9.01 exhibits attached, signaling a company-initiated disclosure outside standard triggers like earnings or M&A. Full filing body not analyzed; description inferred from form + item codes. PMs should review the exhibit for context — 8.01 filings can range from minor updates to material business developments (regulatory, capacity, customer wins).

Intel filed its Q1 2026 quarterly report covering the period ended March 28, 2026. Full filing body not analyzed; description inferred from form + item codes. PMs should review for foundry segment losses, AI accelerator traction, gross margin trajectory, and any updated capex guidance impacting the broader semiconductor cycle.

Filing reports a change among Intel's executive officers or board (Item 5.02), with supporting exhibits attached under Item 9.01. Materiality hinges on whether the named individual is the CEO, CFO, or another key executive versus a routine board rotation; absent that detail, treat as a watch-item rather than a thesis-mover. Full filing body not analyzed; description inferred from form + item codes.

Item 2.02 indicates Intel furnished Q1 2026 results, with Item 9.01 attaching the earnings press release as an exhibit. Full filing body not analyzed; description inferred from form + item codes. PMs should watch DCG/foundry revenue trajectory, gross margin progression, and any updated guidance — Intel prints set the tone for global semi sentiment and read across to Samsung Foundry and TSMC.

Intel filed an 8-K under Item 8.01 (Other Material Events) with supporting exhibits (Item 9.01), indicating a disclosure management deemed material outside standard 8-K triggers — possibly a strategic update, litigation development, capacity/foundry milestone, or regulatory matter. Full filing body not analyzed; description inferred from form + item codes. PMs should pull the exhibit to determine whether this affects the foundry roadmap, AI accelerator positioning, or capital allocation thesis.

Intel disclosed an officer or director change alongside supporting exhibits. Materiality hinges on whether the role involved is CEO/CFO or a non-key executive — without that detail, treat as routine governance. Full filing body not analyzed; description inferred from form + item codes.

Intel filed an 8-K under Items 7.01 (Reg FD), 8.01 (Other Events), and 9.01 (Exhibits), signaling new public commentary likely tied to forward outlook or strategic update outside the normal earnings cycle. PMs should check for revised guidance, foundry/AI roadmap remarks, or capacity commentary that could re-rate near-term estimates and shift sentiment across the broader semi complex (incl. KR/TW peers). Full filing body not analyzed; description inferred from form + item codes.

Intel filed its FY2025 10-K covering the fiscal year ended 2025-12-27, the comprehensive annual disclosure including audited financials, segment results (foundry/products), risk factors, and MD&A. PMs should mine this for foundry ramp progress (18A node, external customer traction), capex trajectory, IFS segment losses, and any going-concern or CHIPS Act language. Full filing body not analyzed; description inferred from form + item codes.

Filing flags an Item 8.01 'other material event' alongside Item 9.01 exhibits, a catch-all used for disclosures that don't fit a specific 8-K item (e.g., strategic updates, litigation, financing actions, or preliminary operational data). Full filing body not analyzed; description inferred from form + item codes. PMs should pull the exhibit to gauge whether it touches foundry strategy, capex, or Q4 print expectations before the late-January earnings window.

Intel filed an 8-K under Item 2.02 announcing its quarterly earnings results, with Item 9.01 attaching the related press release and financial exhibits. PMs should review revenue, DCAI/CCG segment splits, foundry margin trajectory, and any forward guidance for read-throughs to Samsung Foundry, TSMC, and Korean/Taiwanese memory and equipment suppliers. Full filing body not analyzed; description inferred from form + item codes.

Intel filed an 8-K under Item 3.02 disclosing an unregistered sale of equity securities, which typically signals a private placement, strategic investment, or securities issued in connection with a financing or acquisition transaction. PMs should watch for dilution magnitude, identity of the purchaser (e.g., strategic partner, sovereign fund, or U.S. government tranche tied to CHIPS Act considerations), and pricing terms. Full filing body not analyzed; description inferred from form + item codes.